Panacea Biotec Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Jun '25 Jun 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2016 - 2020
Cash & Equivalents	-	821.25	471.74	398.52	503.5	520.79	Upgrade
Short-Term Investments	-	440.91	638.99	1,598	4,963	390.99	Upgrade
Trading Asset Securities	-	31.53	403.62	134.16	50.01	-	Upgrade
Cash & Short-Term Investments	1,101	1,294	1,514	2,130	5,516	911.78	Upgrade
Cash Growth	-38.77%	-14.57%	-28.92%	-61.38%	505.00%	74.95%	Upgrade
Accounts Receivable	-	725.57	574.19	600.92	816.56	846.84	Upgrade
Other Receivables	-	11.58	10.57	12.02	10.58	63.42	Upgrade
Receivables	-	762.82	618.08	628.74	841.54	930.21	Upgrade
Inventory	-	2,137	1,779	2,021	2,127	1,741	Upgrade
Prepaid Expenses	-	71.08	60.63	52.2	53.49	52.87	Upgrade
Other Current Assets	-	1,187	882.26	850.84	1,367	1,473	Upgrade
Total Current Assets	-	5,452	4,855	5,683	9,906	5,110	Upgrade
Property, Plant & Equipment	-	6,369	6,348	6,163	6,255	6,279	Upgrade
Long-Term Investments	-	1.17	1.72	1.74	803.91	5.52	Upgrade
Other Intangible Assets	-	360.91	276.32	153.3	132.36	139.71	Upgrade
Long-Term Deferred Tax Assets	-	-	-	-	237.51	1.47	Upgrade
Long-Term Deferred Charges	-	61.71	83.66	106.11	5.88	12.5	Upgrade
Other Long-Term Assets	-	652.84	843.43	600.99	248.48	227.46	Upgrade
Total Assets	-	12,897	12,408	12,712	17,589	11,775	Upgrade
Accounts Payable	-	2,258	1,456	1,773	2,347	2,467	Upgrade
Accrued Expenses	-	369.66	439.6	361.43	404.63	381.76	Upgrade
Short-Term Debt	-	-	-	0.55	-	-	Upgrade
Current Portion of Long-Term Debt	-	-	-	-	0.52	844.46	Upgrade
Current Income Taxes Payable	-	0.08	1.35	5.6	0.85	0.26	Upgrade
Current Unearned Revenue	-	17.69	171.03	196.62	-	-	Upgrade
Other Current Liabilities	-	1,025	1,022	980.88	5,010	797.87	Upgrade
Total Current Liabilities	-	3,670	3,090	3,318	7,764	4,491	Upgrade
Long-Term Debt	-	222.06	209.94	201.64	341.03	7,351	Upgrade
Long-Term Unearned Revenue	-	108.52	218.46	321.39	455.88	29.06	Upgrade
Pension & Post-Retirement Benefits	-	191.06	164.51	134.25	144.26	172.08	Upgrade
Long-Term Deferred Tax Liabilities	-	232.82	225.45	203.71	-	-	Upgrade
Other Long-Term Liabilities	-	166.91	117.78	131.22	147.3	2,049	Upgrade
Total Liabilities	-	4,591	4,026	4,311	8,852	14,092	Upgrade
Common Stock	-	61.25	61.25	61.25	61.25	61.25	Upgrade
Additional Paid-In Capital	-	919.4	919.4	919.4	919.4	919.4	Upgrade
Retained Earnings	-	8,594	8,678	8,694	9,041	-1,745	Upgrade
Comprehensive Income & Other	-	-1,443	-1,455	-1,455	-1,472	-1,739	Upgrade
Total Common Equity	8,348	8,131	8,204	8,219	8,550	-2,503	Upgrade
Minority Interest	-	-41.7	-38.21	-34.89	-29.81	-30	Upgrade
Shareholders' Equity	8,306	8,306	8,382	8,401	8,737	-2,317	Upgrade
Total Liabilities & Equity	-	12,897	12,408	12,712	17,589	11,775	Upgrade
Total Debt	222.1	222.06	209.94	202.19	341.55	8,195	Upgrade
Net Cash (Debt)	879.1	1,072	1,304	1,928	5,175	-7,283	Upgrade
Net Cash Growth	-44.66%	-17.85%	-32.35%	-62.74%	-	-	Upgrade
Net Cash Per Share	14.37	17.50	21.30	31.48	84.48	-118.91	Upgrade
Filing Date Shares Outstanding	61.36	61.25	61.25	61.25	61.25	61.25	Upgrade
Total Common Shares Outstanding	61.36	61.25	61.25	61.25	61.25	61.25	Upgrade
Working Capital	-	1,782	1,765	2,365	2,142	618.81	Upgrade
Book Value Per Share	136.92	132.75	133.94	134.19	139.59	-40.87	Upgrade
Tangible Book Value	7,925	7,770	7,928	8,066	8,417	-2,643	Upgrade
Tangible Book Value Per Share	129.99	126.86	129.43	131.69	137.43	-43.15	Upgrade
Land	-	2,068	2,059	2,059	2,027	1,773	Upgrade
Buildings	-	3,155	3,196	3,333	3,333	3,286	Upgrade
Machinery	-	6,624	6,442	6,509	6,512	6,258	Upgrade
Construction In Progress	-	935.13	747.15	280.07	49.12	212.41	Upgrade

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.